State of Wyoming’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

State of Wyoming’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-19	Closed	-$1K	–	2057
2022 Q2	$1K	Buy	19 +4	+27%	+$119	﹤0.01%	1823
2022 Q1	$0	Buy	15 +3	+25%	+$89	﹤0.01%	2086
2021 Q4	$0	Sell	12 -1	-8%	-$77	﹤0.01%	2006
2021 Q3	$1K	Sell	13 -6	-32%	-$703	﹤0.01%	1199
2021 Q2	$3K	Buy	19 +10	+111%	+$1.13K	﹤0.01%	1106
2021 Q1	$1K	Buy	+9	New	+$1.05K	﹤0.01%	503

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State of Wyoming's RETA Position: Q3 2022 in Review

State of Wyoming sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2022, closing a stake of 19 shares — an estimated $1K sold.

State of Wyoming first reported a position in RETA in Q1 2021 and held it in 6 quarters. The position peaked at $3K in Q2 2021. 159 funds tracked by Wall St. Rank hold RETA as of Q3 2022.

State of Wyoming reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 19 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2022, an estimated $1K.
State of Wyoming first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2021 and held it in 6 quarters.
State of Wyoming's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $3K in Q2 2021.
159 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.